2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights

Authors

Amgad Albohy, The British University in EgyptFollow

Document Type

Article

Publication Date

2022

Recommended Citation

Albohy, Amgad, "2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights" (2022). Pharmacy. 616.
https://buescholar.bue.edu.eg/pharmacy/616